The groundbreaking approach of this peptide represents a major development in the management of the condition. Unlike existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment